FRANKLIN LAKES, N.J., Oct. 26 Executives for Medco Health Solutions, Inc. (NYSE: MHS) are scheduled to present at the following investor conferences:
Timothy Wentworth, Medco's group president for employer accounts, will address the Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, 2009 at 2:10 p.m. ET at The Waldorf-Astoria Hotel in New York;
David B. Snow Jr., Medco chairman and CEO, will address the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009 at 10:25 a.m. ET at The St. Regis Hotel in New York.
Richard J. Rubino, chief financial officer, is also scheduled to attend these conferences.
In addition, Dr. Robert S. Epstein, Medco's chief medical officer, will address the 2nd Annual Sanford C. Bernstein Biosimilars Conference on Thursday, November 19, 2009 at 11:30 a.m. ET at the AllianceBernstein Headquarters in New York.
These presentations may be heard live via a simulcast link and the accompanying slides will be available at www.medcohealth.com/investor. Real Player or Windows Media Player is required to listen to the webcast. Free downloads of both players are available at the webcast site. The webcast will be available for replay for one month following the presentation.
Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter(TM) for more than 60 million members.
With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2008 revenue exceeding $51 billion, Medco ranks 45th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.
For more information, go to http://www.medcohealth.com.
SOURCE Medco Health Solutions, Inc.